| Name | Title | Contact Details |
|---|
Allied Benefit Systems is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
D1 Sports Training and Therapy is a Franklin, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Focused on improving the health of student populations, TimelyMD offers universities and colleges a comprehensive, custom program centered around telehealth. TimelyMD`s campus-wide solution gives students one point of contact--anytime, anywhere--to get quality care and immediate treatment for medical or mental health concerns from board certified physicians and licensed counselors. TimelyMD`s telehealth programs optimize clinic resources and support clinic staff in delivering quality care to the right students at the right times.
Capital Rx is built around the mission of changing the way prescription drugs are priced and patients are serviced. A health technology company daring to reimagine the pharmacy benefits industry, Capital Rx is executing on that mission through its Clearinghouse Model® - the first ethical framework for drug pricing. Capital Rx`s enterprise pharmacy platform, JUDI™, connects every aspect of the pharmacy ecosystem in one platform, enabling patient engagement, and increasing efficiency to achieve the highest standards of clinical care.
Mr. Gallagher is Senior Vice President & Chief Financial Officer at RRD International, LLC. Mr. Gallagher provides strategic, operational, and financial leadership to RRD. His primary responsibilities are planning, implementing, managing, and controlling all financial-related activities including the development of financial and operational strategies. Mr. Gallagher has over 20 years of finance experience in the biopharma industry with both multi-national corporations and commercial-stage public biotechnology companies. He has an extensive background in all areas of corporate controllership, including financial planning & analysis, cost control, management accounting, corporate administration, and systems implementation. He has supported all aspects of product development and commercialization, including the negotiation and execution of licensing and collaboration agreements with major pharma partners. Mr. Gallagher served previously as Vice President of Finance for Optimer Pharmaceuticals and, prior to that, as Senior Director of Finance and Corporate Controller for Adolor Corporation. He had a central role in the sale of both companies. Mr. Gallagher spent the first 10 years of his career with Therakos, Inc. (a Johnson & Johnson company) and Merck & Co., Inc. He received his BS in Finance from The Pennsylvania State University and is an active Certified Management Accountant (CMA).